RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer
Clinical trial NCT05862051 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05862051
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2025-12-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.